Seeking Alpha

QualityStocks'  Instablog

QualityStocks
Send Message
QualityStocks (www.qualitystocks.net) assists publicly traded companies by getting their story out to the investment community while helping investors discover emerging companies with plenty of growth potential. Our name, QualityStocks, emphasizes our commitment to connect subscribers with... More
My company:
QualityStocks
My blog:
QualityStocks Micro-Cap and Small-Cap Blog
  • International Stem Cell Corp. (ISCO) Leading The Charge Against Neurological Diseases 0 comments
    Jul 26, 2013 1:39 PM | about stocks: ISCO

    Neurological diseases, disorders of the brain, spinal cord, and nerves, have traditionally been among the most difficult diseases to treat. Information regarding the detailed behavior of nerve and brain cells has been slow to develop, and dealing with nerve related problems at the cellular level has only recently become possible. Until now, there has been relatively little hope for addressing or even understanding such diseases. The good news is that more progress in understanding and dealing with neurological diseases has been made in the past 20 years than in all previous years combined. Stem cell technology in particular has shown promise in dealing with such diseases, by providing a viable way of replacing damaged nerve cells with healthy stem cell generated neuronal cells.

    Parkinson's disease is a good example. Parkinson's is a degenerative nerve disease, where dopamine-generating cells in the brain start to die. Dopamine is an important neurotransmitter, which, together with other neurotransmitters, produces the complex pattern of nerve signals that control the body's muscles. Without it, nerve and muscle communication breaks down, resulting in reduced muscle control. As conditions worsen over time, the patient can develop severe tremors, and have difficulty balancing and walking. Internal and cognitive problems can eventually occur, and life expectancy is reduced.

    Scientists now see stem cell technology as offering the best hope for a cure for Parkinson's, and real progress is being made every day. Using their own unique parthenogenetic stem cell (hpSC) technology, scientists at International Stem Cell are now able to derive neuronal cells that are suitable for implantation, and these cells have been demonstrated to successfully treat Parkinson's symptoms. Parthenogenetic cells, unique to ISCO, are of particular value because they don't have the immune matching problems of other stem cells, and a relatively small number hpSC lines could provide sufficient immune-matched cells to cover a large percentage of the world's population.

    For more information, visit internationalstemcell.com

    Please see disclaimer on the QualityStocks website: disclaimer.qualitystocks.net

    Stocks: ISCO
Back To QualityStocks' Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers

StockTalks

More »
Posts by Themes
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.